Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]
Sanofi Establishes Three-year Collaboration with Stanford Medicine to Accelerate Immunology Research
Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together, […]
Sanofi Acquires Tidal Therapeutics
Sanofi today acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more